Last reviewed · How we verify

NCT03445455: VOLHYPOX

Assessment of Tidal Volume During Non Invasive Oxygenation Techniques

Status unknown Last updated 2 March 2018
What this trial tests

trial testing Tidal volume measurement in Respiratory Failure With Hypoxia in 25 participants. Status unknown.

Timeline
1 March 2018
Primary endpoint
30 June 2019
1 September 2019

Quick facts

Lead sponsorHenri Mondor University Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment25
Start date1 March 2018
Primary completion30 June 2019
Estimated completion1 September 2019

Drugs / interventions tested

Conditions studied

Sponsor

Henri Mondor University Hospital

Who can join

18 and older, any sex, with Respiratory Failure With Hypoxia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High Tidal volume is one of the main mechanisms that lead to lung injuries under mechanical ventilation (ventilator induced lung injury: VILI). It could also induce lung damage during spontaneous or assisted ventilation (patient-self inflicted lung injury: P-SILI). Different non invasive oxygenation devices are available to deliver oxygen during acute hypoxemic respiratory failure: high concentration mask, high flow nasal canula and non-invasive ventilation (with bucco-nasal mask or helmet). The investigators hypothesized that the device may influence the tidal volume. Therefore, the objective of this study is to measure and compare the tidal volume during the use of each device. Tidal volume will be measured using Electrical impedence tomography.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Respiratory Failure With Hypoxia

Currently open trials in the same condition.

Other Henri Mondor University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03445455.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing